Good MorningEquity markets started the week on weakened footing following the start of Trump's tariffs. However, the news isn't all bad. Investors bought the early morning weakness, leaving the S&P 500 well off the session's lows by the day's end. The takeaway is that Trump's tariffs will likely cause market volatility, but the upward trend is intact, and new all-time-high index prices are possible.
Earnings will help drive the action this week. After the Monday close, an after-hours report from Palantir underscored the impact of AI on business, leading its stock to a 15% gain. Other critical reports include Advanced Micro Devices, Amazon, and Google, all expected to report solidly.
Critical economic data is also expected this week. Monthly labor data are due, including the ADP, Challenger, JOLTs, and non-farm payroll reports. The consensus is that the data align with trends, including steady job creation, low unemployment, and rising wages. Featured: DOGE unleashed (read Section Four immediately) (Altimetry) 
|
Stocks | | |
Starting small is usually good advice when beginning a new endeavor. If you’re trying to get back in shape, a quick run or light workout is a better starting point than a marathon. However, that logic is counterintuitive when it comes to stocks. Bigger stocks tend to be safer and less volati... Read the Full Story |
|
From Our PartnersWhile other cell phone carriers are always looking for ways to squeeze every last penny out of their customers, my company pays users for the 40 hours a week they are using smartphone apps, listening to music, and watching videos online with their phones.
And you can join us for just $0.26 per share. Plus, when you invest now, you can get up to 100% bonus shares! | | | | Let’s change the future of mobile together. |
|
Markets | | |
The stock market is going through a historical cycle right now, and most investors aren’t aware of it, given the composition and weighting of the broader S&P 500 and Nasdaq-100 indexes. Considering that these indexes hold mostly stocks inside the technology sector, a concentration of sto... Read the Full Story |
|
Markets | | | Calm returned to Wall Street Tuesday, and tech stocks led U.S. indexes higher following a strong profit report from Palantir Technologies, a darling benefiting from the artificial-intelligence boom.The S&P 500 rose 0.7% a day after swinging sharply on worries that President Donald Trump’s tarif... Read the Full Story |
|
From Our PartnersElon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. | | | | I urge you to watch this video now. |
|
Markets | | | China has announced retaliatory tariffs on select American imports and an antitrust investigation into Google, just minutes after a sweeping levy on Chinese products imposed by U.S. President Donald Trump took effect Read the Full Story |
|
Markets | | | Companies in a wide range of industries saw their stocks come under pressure Monday on Wall Street because of tariff threats from President Donald Trump.Automakers, technology companies and retailers all fell as the U.S., Mexico, Canada and China wrangled over tariffs. Trump said over the weekend th... Read the Full Story |
|
From Our PartnersBillionaire Sam Altman has become one of the most powerful men in the world by running OpenAI…
But there’s a far lesser known investment he’s making that could put OpenAI to shame.
In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI…
And the US Military… not to mention hundreds of other giant companies around the globe.
To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office…
Which ordered the government to take this incredible new technology seriously. | | | | Check out our report right here. |
|
Markets | | |
The principle of momentum investing—though contrary to the traditional wisdom of buying low and selling high—suggests that investors can profit by buying rising stocks and selling them before they decline. As a result, momentum is typically favored in short-term and active trading stra... Read the Full Story |
|
Markets | | |
Arguably late to the AI game, Apple’s (NASDAQ: AAPL) understated push into AI has it set up to grow substantially over the next decade. Ultimately, it won’t be about the flashiness of the AI product or launch, but its durability, and Apple has proven to be a durable business. The compa... Read the Full Story |
|
Markets | | | President Donald Trump on Monday signed an executive order directing the U.S. to take steps to start developing a government-owned investment fund that he said could be used to profit off of TikTok if he’s successful at finding the company an American buyer Read the Full Story |
|
Markets | | |
The Wall Street Journal pointed out a peculiar new trend on social media, where influencers are not showcasing their lavish purchases but rather going the opposite route, embracing a “No Buy” trend. Consumers are tired of inflation and lofty credit card interest rates and have deemed 2... Read the Full Story |
|
Markets | | | PepsiCo said Tuesday that high prices and changing consumer tastes have weakened U.S. demand for its snacks and drinks but it's confident it can turn that around in the coming year.The Purchase, New York-based company said its revenue fell slightly to $27.78 billion in the fourth quarter. That was s... Read the Full Story |
|
Tuesday's Early Bird Stock Of The Day CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island. | Should I Buy CVS Health Stock? CVS Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of CVS Health was last updated on Saturday, January 25, 2025 at 9:34 PM.
CVS Health Bull Case -
CVS Health Co. has shown strong financial performance, reporting a quarterly revenue of $95.43 billion, exceeding analysts' expectations of $92.72 billion. This indicates robust demand for its services and products.
-
The company recently announced a quarterly dividend of $0.665, which translates to an annualized yield of 4.86%. This consistent dividend payment can provide a steady income stream for investors.
-
CVS Health Co. has a market capitalization of approximately $68.84 billion, which reflects its significant presence in the healthcare sector and potential for growth.
-
Analysts have a consensus rating of "Moderate Buy" for CVS Health Co., with an average target price of $68.71, suggesting that there is optimism about the stock's future performance.
-
The current stock price is $54.71, which may present a buying opportunity for investors looking to enter at a lower price point compared to the average target price set by analysts.
CVS Health Bear Case -
CVS Health Co. has faced a decrease in stock price targets from various analysts, with Royal Bank of Canada lowering its price objective from $68.00 to $58.00, indicating potential concerns about future performance.
-
The company has a debt-to-equity ratio of 0.80, which suggests that it has a significant amount of debt compared to its equity. High debt levels can pose risks, especially in a rising interest rate environment.
-
Despite a strong revenue report, CVS Health Co. reported a net margin of only 1.36%, which may indicate challenges in profitability and cost management.
-
One analyst has issued a sell rating on the stock, which could signal caution among some investors regarding the company's future prospects.
-
CVS Health Co. has experienced fluctuations in its stock price, with a 1-year low of $43.56, which may raise concerns about its stability and long-term growth potential.
| | View Today's Stock Pick |
|
